| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |